SCHEMBL16245392

SCHEMBL16245392

COc1cc2sc(-c3c(-c4cccc(F)c4)n[nH]c3N)nc2cc1F.COc1cc2sc(-c3c(C4CC4)n[nH]c3N)nc2cc1F

nearest known ligand 0.62

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ILK Q13418 20/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL686901 0.91 ILK (0.73) ILK
SCHEMBL16245393 0.89 ILK (0.57) ILK
SCHEMBL680171 0.88 ILK (0.71) ILK
SCHEMBL686631 0.83 ILK (0.71) ILK
SCHEMBL686429 0.81 ILK (0.71) ILK
SCHEMBL686460 0.79 ILK (0.76) ILK
SCHEMBL686892 0.79 ILK (0.73) ILK
SCHEMBL687044 0.79 ILK (0.72) ILK
SCHEMBL31061634 0.77 ILK (0.72) ILK
SCHEMBL686446 0.77 ILK (0.72) ILK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140350009-A1 PYRAZOLYLBENZOTHIAZOLE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS DERMIRA (CANADA), INC. (US) 2014-11-27 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140350009-A1 PYRAZOLYLBENZOTHIAZOLE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS COXFA4L2, TYR, XDH ILK 4705/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.